NCT06105541View on ClinicalTrials.gov

Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Hypermobile Ehlers-Danlos SyndromeHypermobile Spectrum DisorderEhlers-Danlos Syndrome
Interventions
DEVICE

Transcutaneous Auricular Neurostimulation

Transcutaneous Auricular Neurostimulation (tAN) is a wearable, electrical stimulation device that delivers electricity to specific parts of the human ear.

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER